Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Friedrich Marks

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Mice

Chemicals & Drugs

Anatomy

Disorders

Skin Neoplasms

Phenomena

Phosphorylation

Concepts & Ideas

Molecular Sequence Data

Genes & Molecular Sequences

Amino Acid Sequence

Physiology

Cell Division

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
62
Fürstenberger, Gerhard
32
Gschwendt, Michael
23
Müller-Decker, Karin
21
Kittstein, W
18
Krieg, Peter
10
Richter, Karl Hartmut
8
Rincke, Gabriele
7
Kinzig, Andreas
6
Heidt, Markus
5
Stempka, Luise
5
Neufang, Gitta
4
Bürger, F
4
Siebert, Malte
3
Johannes, FJ
2
Furstenberger, Gerhard

Sign-in to see all Coauthors

Publications

TOP 3
Marks Friedrich; Fürstenberger Gerhard; Müller-Decker Karin
Tumor promotion as a target of cancer prevention.
Müller-Decker Karin; Manegold Gwendolin; Butz Herbert; Hinz Detlef E; Hüttner Dirk; Richter K Hartmut; Tremmel Matthias; Weissflog Rico; Marks Friedrich
Inhibition of cell proliferation by bacterial lipopolysaccharides in TLR4-positive epithelial cells: independence of nitric oxide and cytokine release.
Müller-Decker Karin; Leder Christoph; Neumann Melanie; Neufang Gitta; Bayerl Christiane; Schweizer Jürgen; Marks Friedrich; Fürstenberger Gerhard
Expression of cyclooxygenase isozymes during morphogenesis and cycling of pelage hair follicles in mouse skin: precocious onset of the first catagen phase and alopecia upon cyclooxygenase-2 overexpression.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Friedrich Marks (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2007: Marks Friedrich; Fürstenberger Gerhard; Müller-Decker Karin
Tumor promotion as a target of cancer prevention.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2007;174():37-47.
2005: Müller-Decker Karin; Manegold Gwendolin; Butz Herbert; Hinz Detlef E; Hüttner Dirk; Richter K Hartmut; Tremmel Matthias; Weissflog Rico; Marks Friedrich
Inhibition of cell proliferation by bacterial lipopolysaccharides in TLR4-positive epithelial cells: independence of nitric oxide and cytokine release.
The Journal of investigative dermatology 2005;124(3):553-61.
2003: Müller-Decker Karin; Leder Christoph; Neumann Melanie; Neufang Gitta; Bayerl Christiane; Schweizer Jürgen; Marks Friedrich; Fürstenberger Gerhard
Expression of cyclooxygenase isozymes during morphogenesis and cycling of pelage hair follicles in mouse skin: precocious onset of the first catagen phase and alopecia upon cyclooxygenase-2 overexpression.
The Journal of investigative dermatology 2003;121(4):661-8.
2003: Marks Friedrich; Fürstenberger Gerhard; Neufang Gitta; Müller-Decker Karin
Mouse skin as a model for cancer chemoprevention by nonsteroidal anti-inflammatory drugs.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2003;163():46-57; discussion 264-6.
2003: Fürstenberger Gerhard; Marks Friedrich; Müller-Decker Karin
Cyclooxygenase-2 and skin carcinogenesis.
Progress in experimental tumor research. Fortschritte der experimentellen Tumorforschung. Progrès de la recherche expérimentale des tumeurs 2003;37():72-89.
2002: Müller-Decker Karin; Hirschner Wolfgang; Marks Friedrich; Fürstenberger Gerhard
The effects of cyclooxygenase isozyme inhibition on incisional wound healing in mouse skin.
The Journal of investigative dermatology 2002;119(5):1189-95.
2002: Muller-Decker Karin; Neufang Gitta; Berger Irina; Neumann Melanie; Marks Friedrich; Furstenberger Gerhard
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(19):12483-8.
2002: Fürstenberger Gerhard; Marks Friedrich; Krieg Peter
Arachidonate 8(S)-lipoxygenase.
Prostaglandins & other lipid mediators 2002;68-69():235-43.
2002: Müller Karsten; Siebert Malte; Heidt Markus; Marks Friedrich; Krieg Peter; Fürstenberger Gerhard
Modulation of epidermal tumor development caused by targeted overexpression of epidermis-type 12S-lipoxygenase.
Cancer research 2002;62(16):4610-6.
2002: Müller-Decker K; Charyalertsak S; Albert C; Reinerth G; Marks F; Fürstenberger G
Cyclooxygenase-2: a molecular target for chemoprevention of epithelial tumors of skin and colon.
Advances in experimental medicine and biology 2002;507():445-8.
2002: Krieg Peter; Heidt Markus; Siebert Malte; Kinzig Andreas; Marks Friedrich; Fürstenberger Gerhard
Epidermis-type lipoxygenases.
Advances in experimental medicine and biology 2002;507():165-70.
2001: Neufang G; Furstenberger G; Heidt M; Marks F; Müller-Decker K
Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(13):7629-34.
2001: Krieg P; Marks F; Fürstenberger G
A gene cluster encoding human epidermis-type lipoxygenases at chromosome 17p13.1: cloning, physical mapping, and expression.
Genomics 2001;73(3):323-30.
2001: Siebert M; Krieg P; Lehmann W D; Marks F; Fürstenberger G
Enzymic characterization of epidermis-derived 12-lipoxygenase isoenzymes.
The Biochemical journal 2001;355(Pt 1):97-104.
2001: Marks F
[Prevention of cancer and Alzheimer disease with non-steroidal anti-inflammatory agents]
Deutsche medizinische Wochenschrift (1946) 2001;126(11):308-13.
2001: Chariyalertsak S; Sirikulchayanonta V; Mayer D; Kopp-Schneider A; Fürstenberger G; Marks F; Müller-Decker K
Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.
Gut 2001;48(1):80-6.
2000: Marks F; Müller-Decker K; Fürstenberger G
A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism.
Toxicology 2000;153(1-3):11-26.
2000: Bhr C; Rohwer A; Stempka L; Rincke G; Marks F; Gschwendt M
DIK, a novel protein kinase that interacts with protein kinase Cdelta. Cloning, characterization, and gene analysis.
The Journal of biological chemistry 2000;275(46):36350-7.
2000: Rennecke J; Richter K H; Häussermann S; Stempka L; Strand S; Stöhr M; Marks F
Biphasic effect of protein kinase C activators on spontaneous and glucocorticoid-induced apoptosis in primary mouse thymocytes.
Biochimica et biophysica acta 2000;1497(3):289-96.
2000: Nair J; Fürstenberger G; Bürger F; Marks F; Bartsch H
Promutagenic etheno-DNA adducts in multistage mouse skin carcinogenesis: correlation with lipoxygenase-catalyzed arachidonic acid metabolism.
Chemical research in toxicology 2000;13(8):703-9.
2000: Heidt M; Fürstenberger G; Vogel S; Marks F; Krieg P
Diversity of mouse lipoxygenases: identification of a subfamily of epidermal isozymes exhibiting a differentiation-dependent mRNA expression pattern.
Lipids 2000;35(7):701-7.
2000: Bürger F; Krieg P; Marks F; Fürstenberger G
Positional- and stereo-selectivity of fatty acid oxygenation catalysed by mouse (12S)-lipoxygenase isoenzymes.
The Biochemical journal 2000;348 Pt 2():329-35.
2000: Müller K; Krieg P; Marks F; Fürstenberger G
Expression of PGF(2alpha) receptor mRNA in normal, hyperplastic and neoplastic skin.
Carcinogenesis 2000;21(5):1063-6.
2000: Manzow S; Richter K H; Stempka L; Fürstenberger G; Marks F
Evidence against a role of general protein kinase C downregulation in skin tumor promotion.
International journal of cancer. Journal international du cancer 2000;85(4):503-7.
1999: Häussermann S; Kittstein W; Rincke G; Johannes F J; Marks F; Gschwendt M
Proteolytic cleavage of protein kinase Cmu upon induction of apoptosis in U937 cells.
FEBS letters 1999;462(3):442-6.
1999: Müller-Decker K; Albert C; Lukanov T; Winde G; Marks F; Fürstenberger G
Cellular localization of cyclo-oxygenase isozymes in Crohn's disease and colorectal cancer.
International journal of colorectal disease 1999;14(4-5):212-8.
1999: Müller-Decker K; Reinerth G; Krieg P; Zimmermann R; Heise H; Bayerl C; Marks F; Fürstenberger G
Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin.
International journal of cancer. Journal international du cancer 1999;82(5):648-56.
1999: Rohwer A; Kittstein W; Marks F; Gschwendt M
Cloning, expression and characterization of an A6-related protein.
European journal of biochemistry / FEBS 1999;263(2):518-25.
1999: Kinzig A; Heidt M; Fürstenberger G; Marks F; Krieg P
cDNA cloning, genomic structure, and chromosomal localization of a novel murine epidermis-type lipoxygenase.
Genomics 1999;58(2):158-64.
1999: Krieg P; Siebert M; Kinzig A; Bettenhausen R; Marks F; Fürstenberger G
Murine 12(R)-lipoxygenase: functional expression, genomic structure and chromosomal localization.
FEBS letters 1999;446(1):142-8.
1999: Stempka L; Schnölzer M; Radke S; Rincke G; Marks F; Gschwendt M
Requirements of protein kinase cdelta for catalytic function. Role of glutamic acid 500 and autophosphorylation on serine 643.
The Journal of biological chemistry 1999;274(13):8886-92.
1999: Bürger F; Krieg P; Kinzig A; Schurich B; Marks F; Fürstenberger G
Constitutive expression of 8-lipoxygenase in papillomas and clastogenic effects of lipoxygenase-derived arachidonic acid metabolites in keratinocytes.
Molecular carcinogenesis 1999;24(2):108-17.
1999: Rennecke J; Rehberger P A; Fürstenberger G; Johannes F J; Stöhr M; Marks F; Richter K H
Protein-kinase-Cmu expression correlates with enhanced keratinocyte proliferation in normal and neoplastic mouse epidermis and in cell culture.
International journal of cancer. Journal international du cancer 1999;80(1):98-103.
1999: Marks F; Fürstenberger G; Müller-Decker K
Metabolic targets of cancer chemoprevention: interruption of tumor development by inhibitors of arachidonic acid metabolism.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1999;151():45-67.
1998: Müller-Decker K; Heinzelmann T; Fürstenberger G; Kecskes A; Lehmann W D; Marks F
Arachidonic acid metabolism in primary irritant dermatitis produced by patch testing of human skin with surfactants.
Toxicology and applied pharmacology 1998;153(1):59-67.
1998: Müller-Decker K; Kopp-Schneider A; Marks F; Seibert K; Fürstenberger G
Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: suppression of skin tumor promotion by inhibition of prostaglandin H synthase-2.
Molecular carcinogenesis 1998;23(1):36-44.
1998: Marks F; Fürstenberger G; Müller-Decker K
Arachidonic acid metabolism as a reporter of skin irritancy and target of cancer chemoprevention.
Toxicology letters 1998;96-97():111-8.
1998: Müller-Decker K; Scholz K; Neufang G; Marks F; Fürstenberger G
Localization of prostaglandin-H synthase-1 and -2 in mouse skin: implications for cutaneous function.
Experimental cell research 1998;242(1):84-91.
1998: Krieg P; Kinzig A; Heidt M; Marks F; Fürstenberger G
cDNA cloning of a 8-lipoxygenase and a novel epidermis-type lipoxygenase from phorbol ester-treated mouse skin.
Biochimica et biophysica acta 1998;1391(1):7-12.
1997: Rehberger P A; Richter K H; Schwartz D; Goldfinger N; Oskato R; Almog N; Marks F; Rotter V
Differential expression of the regularly spliced wild-type p53 and its COOH-terminal alternatively spliced form during epidermal differentiation.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997;8(8):851-60.
1997: Krieg P; Schuppler M; Koesters R; Mincheva A; Lichter P; Marks F
Repetin (Rptn), a new member of the "fused gene" subgroup within the S100 gene family encoding a murine epidermal differentiation protein.
Genomics 1997;43(3):339-48.
1997: Gschwendt M; Johannes F J; Kittstein W; Marks F
Regulation of protein kinase Cmu by basic peptides and heparin. Putative role of an acidic domain in the activation of the kinase.
The Journal of biological chemistry 1997;272(33):20742-6.
1997: Stempka L; Girod A; Müller H J; Rincke G; Marks F; Gschwendt M; Bossemeyer D
Phosphorylation of protein kinase Cdelta (PKCdelta) at threonine 505 is not a prerequisite for enzymatic activity. Expression of rat PKCdelta and an alanine 505 mutant in bacteria in a functional form.
The Journal of biological chemistry 1997;272(10):6805-11.
1997: Kinzig A; Fürstenberger G; Bürger F; Vogel S; Müller-Decker K; Mincheva A; Lichter P; Marks F; Krieg P
Murine epidermal lipoxygenase (Aloxe) encodes a 12-lipoxygenase isoform.
FEBS letters 1997;402(2-3):162-6.
1997: Fürstenberger G; Hess M; Kast R; Marks F
Expression of two cPLA2 isoforms in mouse epidermis in vivo.
Advances in experimental medicine and biology 1997;400A():425-31.
1997: Fürstenberger G; Müller-Decker K; Scholz K; Löschke M; Lehmann W D; Marks F
Different expression of prostaglandin-H synthase isozymes and lipoxygenases during multistage carcinogenesis in mouse skin.
Advances in experimental medicine and biology 1997;400A():419-24.
1997: Löschke M; Kriec P; Lehmann W D; Marks F; Fürstenberger G
Purification and characterization of the epidermal 8(S)lipoxygenase.
Advances in experimental medicine and biology 1997;400A():139-44.
1996: Rennecke J; Johannes F J; Richter K H; Kittstein W; Marks F; Gschwendt M
Immunological demonstration of protein kinase C mu in murine tissues and various cell lines. Differential recognition of phosphorylated forms and lack of down-regulation upon 12-O-tetradecanoylphorphol-13-acetate treatment of cells.
European journal of biochemistry / FEBS 1996;242(2):428-32.
1996: Manzow S; Brancolini C; Marks F; Richter K H
Expression of growth arrest-specific (Gas) genes in murine keratinocytes: Gas2 is specifically regulated.
Experimental cell research 1996;224(1):200-3.
1996: Bartsch H; Frank N; Frei E; Marks F; Schroeder C H; Lin J K
Taiwanese-German workshop on tumour prevention.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 1996;5(1):83-8.
1996: Hanke B; Fürstenberger G; Marks F
Relationship between TGF alpha-induced DNA synthesis and prostaglandin synthesis in human HaCaT keratinocytes.
Biochimica et biophysica acta 1996;1310(1):137-44.
1995: Marks F; Fürstenberger G; Heinzelmann T; Müller-Decker K
Mechanisms in tumor promotion: guidance for risk assessment and cancer chemoprevention.
Toxicology letters 1995;82-83():907-17.
1995: Krieg P; Kinzig A; Ress-Löschke M; Vogel S; Vanlandingham B; Stephan M; Lehmann W D; Marks F; Fürstenberger G
12-Lipoxygenase isoenzymes in mouse skin tumor development.
Molecular carcinogenesis 1995;14(2):118-29.
1995: Geiges D; Marks F; Gschwendt M
Loss of protein kinase C delta from human HaCaT keratinocytes upon ras transfection is mediated by TGF alpha.
Experimental cell research 1995;219(1):299-303.
1995: Scholz K; Fürstenberger G; Müller-Decker K; Marks F
Differential expression of prostaglandin-H synthase isoenzymes in normal and activated keratinocytes in vivo and in vitro.
The Biochemical journal 1995;309 ( Pt 1)():263-9.
1995: Kielbassa K; Müller H J; Meyer H E; Marks F; Gschwendt M
Protein kinase C delta-specific phosphorylation of the elongation factor eEF-alpha and an eEF-1 alpha peptide at threonine 431.
The Journal of biological chemistry 1995;270(11):6156-62.
1995: Gschwendt M; Kittstein W; Kielbassa K; Marks F
Protein kinase C delta accepts GTP for autophosphorylation.
Biochemical and biophysical research communications 1995;206(2):614-20.
1995: Müller-Decker K; Scholz K; Marks F; Fürstenberger G
Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis.
Molecular carcinogenesis 1995;12(1):31-41.
1994: Fürstenberger G; Csuk-Glänzer B I; Marks F; Keppler D
Phorbol ester-induced leukotriene biosynthesis and tumor promotion in mouse epidermis.
Carcinogenesis 1994;15(12):2823-7.
1994: Zang R; Müller H J; Kielbassa K; Marks F; Gschwendt M
Partial purification of a type eta protein kinase C from murine brain: separation from other protein kinase C isoenzymes and characterization.
The Biochemical journal 1994;304 ( Pt 2)():641-7.
1994: Ushmorov A G; Fürstenberger G; Faissner A; Marks F
Effects of complete and incomplete tumor promoters on hair growth, angiogenesis, and tenascin expression in the skin of NMRI mice.
Carcinogenesis 1994;15(12):2739-45.
1994: Müller-Decker K; Fürstenberger G; Marks F
Keratinocyte-derived proinflammatory key mediators and cell viability as in vitro parameters of irritancy: a possible alternative to the Draize skin irritation test.
Toxicology and applied pharmacology 1994;127(1):99-108.
1994: Gschwendt M; Kielbassa K; Kittstein W; Marks F
Tyrosine phosphorylation and stimulation of protein kinase C delta from porcine spleen by src in vitro. Dependence on the activated state of protein kinase C delta.
FEBS letters 1994;347(1):85-9.
1994: Gschwendt M; Müller H J; Kielbassa K; Zang R; Kittstein W; Rincke G; Marks F
Rottlerin, a novel protein kinase inhibitor.
Biochemical and biophysical research communications 1994;199(1):93-8.
1994: Gschwendt M; Kittstein W; Marks F
Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine.
FEBS letters 1994;338(1):85-8.
1993: Marks F; Fürstenberger G
Proliferative responses of the skin to external stimuli.
Environmental health perspectives 1993;101 Suppl 5():95-101.
1993: Kast R; Fürstenberger G; Marks F
Phorbol ester TPA- and bradykinin-induced arachidonic acid release from keratinocytes is catalyzed by a cytosolic phospholipase A2 (cPLA2).
The Journal of investigative dermatology 1993;101(4):567-72.
1993: Kast R; Fürstenberger G; Marks F
Activation of cytosolic phospholipase A2 by transforming growth factor-alpha in HEL-30 keratinocytes.
The Journal of biological chemistry 1993;268(22):16795-802.
1993: Gschwendt M; Kittstein W; Marks F
Protein kinase C forms a complex with and phosphorylates the GTPase activating protein GAP: phosphorylation by PKC is dependent on tyrosine phosphorylation of GAP and/or a GAP-associated protein.
Biochemical and biophysical research communications 1993;194(1):571-6.
1993: Marks F
Skin carcinogenesis: a health problem meets with a scientific challenge concluding remarks and future prospects.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;128():353-8.
1993: Fürstenberger G; Krieg P; Schnapke R; Feil S; Marks F
The role of endogenous factors in skin carcinogenesis.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;128():323-37.
1992: Gschwendt M; Kittstein W; Lindner D; Marks F
Differential inhibition by staurosporine of phorbol ester, bryostatin and okadaic acid effects on mouse skin.
Cancer letters 1992;66(2):139-46.
1992: Gschwendt M; Leibersperger H; Kittstein W; Marks F
Protein kinase C zeta and eta in murine epidermis. TPA induces down-regulation of PKC eta but not PKC zeta.
FEBS letters 1992;307(2):151-5.
1992: Lindner D; Gschwendt M; Marks F
Phorbol ester-induced down-regulation of the 80-kDa myristoylated alanine-rich C-kinase substrate-related protein in Swiss 3T3 fibroblasts. Inhibition by staurosporine.
The Journal of biological chemistry 1992;267(1):24-6.
1991: Kast R; Fürstenberger G; Marks F
Activation of a keratinocyte phospholipase A2 by bradykinin and 4 beta-phorbol 12-myristate 13-acetate. Evidence for a receptor-GTP-binding protein versus a protein-kinase-C mediated mechanism.
European journal of biochemistry / FEBS 1991;202(3):941-50.
1991: Gschwendt M; Leibersperger H; Rincke G; Marks F
Immunological demonstration of epsilon PKC. Murine tissue distribution, ontogeny, cellular localization and translocation.
FEBS letters 1991;290(1-2):115-8.
1991: Marks F; Hanke B; Thastrup O; Fürstenberger G
Stimulatory effect of thapsigargin, a non-TPA-type tumor promoter, on arachidonic acid metabolism in the murine keratinocyte line HEL30 and on epidermal cell proliferation in vivo as compared to the effects of phorbol ester TPA.
Carcinogenesis 1991;12(8):1491-7.
1991: Fürstenberger G; Hagedorn H; Jacobi T; Besemfelder E; Stephan M; Lehmann W D; Marks F
Characterization of an 8-lipoxygenase activity induced by the phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate in mouse skin in vivo.
The Journal of biological chemistry 1991;266(24):15738-45.
1991: Leibersperger H; Gschwendt M; Gernold M; Marks F
Immunological demonstration of a calcium-unresponsive protein kinase C of the delta-type in different species and murine tissues. Predominance in epidermis.
The Journal of biological chemistry 1991;266(22):14778-84.
1991: Lindner D; Gschwendt M; Marks F
Down-regulation of protein kinase C in Swiss 3T3 fibroblasts is independent of its phosphorylating activity.
Biochemical and biophysical research communications 1991;176(3):1227-31.
1991: Krieg P; Schnapke R; Fürstenberger G; Vogt I; Marks F
TGF-beta 1 and skin carcinogenesis: antiproliferative effect in vitro and TGF-beta 1 mRNA expression during epidermal hyperproliferation and multistage tumorigenesis.
Molecular carcinogenesis 1991;4(2):129-37.
1990: Marks F; Fürstenberger G
The conversion stage of skin carcinogenesis.
Carcinogenesis 1990;11(12):2085-92.
1990: Leibersperger H; Gschwendt M; Marks F
Purification and characterization of a calcium-unresponsive, phorbol ester/phospholipid-activated protein kinase from porcine spleen.
The Journal of biological chemistry 1990;265(27):16108-15.
1990: Richter K H; Schnapke R; Clauss M; Fürstenberger G; Hinz D; Marks F
Epidermal G1-chalone and transforming growth factor-beta are two different endogenous inhibitors of epidermal cell proliferation.
Journal of cellular physiology 1990;142(3):496-504.
1989: Gschwendt M; Leibersperger H; Marks F
Differentiative action of K252a on protein kinase C and a calcium-unresponsive, phorbol ester/phospholipid-activated protein kinase.
Biochemical and biophysical research communications 1989;164(3):974-82.
1989: Gschwendt M; Kittstein W; Mieskes G; Marks F
A type 2A protein phosphatase dephosphorylates the elongation factor 2 and is stimulated by the phorbol ester TPA in mouse epidermis in vivo.
FEBS letters 1989;257(2):357-60.
1989: Gschwendt M; Kittstein W; Horn F; Leibersperger H; Marks F
A phorbol ester and phospholipid-activated, calcium-unresponsive protein kinase in mouse epidermis: characterization and separation from protein kinase C.
Journal of cellular biochemistry 1989;40(3):295-307.
1989: Gschwendt M; Kittstein W; Marks F
Cyclosporine A suppresses an early process in phorbol ester action.
Cancer letters 1989;46(2):113-5.
1989: Tiegel A; Richter K H; Marks F
Cell cycle specificity and reversibility of the inhibitory effect of epidermal G1-chalone on DNA synthesis in partially synchronized RTE-2 keratinocytes in vitro.
Experimental cell research 1989;182(2):297-306.
1989: Fürstenberger G; Rogers M; Schnapke R; Bauer G; Höfler P; Marks F
Stimulatory role of transforming growth factors in multistage skin carcinogenesis: possible explanation for the tumor-inducing effect of wounding in initiated NMRI mouse skin.
International journal of cancer. Journal international du cancer 1989;43(5):915-21.
1989: Fürstenberger G; Schurich B; Kaina B; Petrusevska R T; Fusenig N E; Marks F
Tumor induction in initiated mouse skin by phorbol esters and methyl methanesulfonate: correlation between chromosomal damage and conversion ('stage I of tumor promotion') in vivo.
Carcinogenesis 1989;10(4):749-52.
1989: Fürstenberger G; Amtmann E; Marks F; Sauer G
Tumor prevention by a xanthate compound in experimental mouse-skin tumorigenesis.
International journal of cancer. Journal international du cancer 1989;43(3):508-12.
1989: Gschwendt M; Kittstein W; Marks F
The immunosuppressant FK-506, like cyclosporins and didemnin B, inhibits calmodulin-dependent phosphorylation of the elongation factor 2 in vitro and biological effects of the phorbol ester TPA on mouse skin in vivo.
Immunobiology 1989;179(1):1-7.
1989: Philipps C; Rose-John S; Rincke G; Fürstenberger G; Marks F
cDNA-cloning, sequencing and expression in glucocorticoid-stimulated quiescent Swiss 3T3 fibroblasts of mouse lipocortin I.
Biochemical and biophysical research communications 1989;159(1):155-62.
1989: Fürstenberger G; Gross M; Marks F
Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion).
Carcinogenesis 1989;10(1):91-6.
1988: Petrusevska R T; Fürstenberger G; Marks F; Fusenig N E
Cytogenetic effects caused by phorbol ester tumor promoters in primary mouse keratinocyte cultures: correlation with the convertogenic activity of TPA in multistage skin carcinogenesis.
Carcinogenesis 1988;9(7):1207-15.
1988: Gschwendt M; Kittstein W; Marks F
Effect of tumor promoting phorbol ester TPA on epidermal protein synthesis: stimulation of an elongation factor 2 phosphatase activity by TPA in vivo.
Biochemical and biophysical research communications 1988;153(3):1129-35.
1988: Rose-John S; Fürstenberger G; Krieg P; Besemfelder E; Rincke G; Marks F
Differential effects of phorbol esters on c-fos and c-myc and ornithine decarboxylase gene expression in mouse skin in vivo.
Carcinogenesis 1988;9(5):831-5.
1988: Gschwendt M; Fürstenberger G; Rose-John S; Rogers M; Kittstein W; Pettit G R; Herald C L; Marks F
Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro.
Carcinogenesis 1988;9(4):555-62.
1988: Gschwendt M; Kittstein W; Marks F
The weak immunosuppressant cyclosporine D as well as the immunologically inactive cyclosporine H are potent inhibitors in vivo of phorbol ester TPA-induced biological effects in mouse skin and of Ca2+/calmodulin dependent EF-2 phosphorylation in vitro.
Biochemical and biophysical research communications 1988;150(2):545-51.
1988: Gschwendt M; Kittstein W; Marks F
Ciclosporin inhibits phorbol-ester-induced hyperplastic transformation and tumor promotion in mouse skin probably by suppression of Ca2+/calmodulin-dependent processes such as phosphorylation of elongation factor 2.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1988;1(2):84-92.
1988: Richter K H; Clauss M; Höfle W; Schnapke R; Marks F
The epidermal G1-chalone: an endogenous tissue-specific inhibitor of epidermal cell proliferation.
Annals of the New York Academy of Sciences 1988;548():204-10.
1986: Gschwendt M; Fürstenberger G; Kittstein W; Besemfelder E; Hull W E; Hagedorn H; Opferkuch H J; Marks F
Generation of the arachidonic acid metabolite 8-HETE by extracts of mouse skin treated with phorbol ester in vivo; identification by 1H-n.m.r. and GC-MS spectroscopy.
Carcinogenesis 1986;7(3):449-55.
1984: Gschwendt M; Horn F; Kittstein W; Fürstenberger G; Besemfelder E; Marks F
Calcium and phospholipid-dependent protein kinase activity in mouse epidermis cytosol. Stimulation by complete and incomplete tumor promoters and inhibition by various compounds.
Biochemical and biophysical research communications 1984;124(1):63-8.

Sign-in to see more